1.HKU yavuze ko urukingo rwa COVID-19 n’urukingo rwa ibicurane bishobora guhurizwa hamwe
urukingo rwa COVID-19 rukinguye rwateguwe na kaminuza ya Hong Kong, kaminuza ya Xiamen na Beijing Wantai Biological Pharmaceutical Co., Ltd. iherutse kwemezwa n’ikigo cya Leta gishinzwe ibiyobyabwenge kugira ngo gikoreshwe byihutirwa ku mugabane wa Afurika.Kaminuza ya Hong Kong yasubije iperereza ry’umunyamakuru w’Ubushinwa ushinzwe amakuru ko kimwe mu biranga uru rukingo rwa COVID-19 ari uko rushobora guhuzwa n’urukingo rw’ibicurane.
2.Waterloo, miliyari 3 zitandukanye, yakoze "ikamba ryo kugurisha" rishya rya antemetics!
Isesemi no kuruka biterwa na chimiotherapie ni imwe mu ngaruka mbi z’abarwayi ba kanseri.Imiti igabanya ubukana hamwe n’imiti igabanya isesemi ishyirwa mu rwego rwa sisitemu yo kurya no gufata imiti ya metabolike, ariko ikoreshwa cyane mu kuvura kuruka biterwa n’imiti irwanya ibibyimba mu mavuriro, kandi bigira uruhare runini mu kuvura ibibyimba.Nk’uko imibare yaturutse muri Minei.com ibigaragaza, ingano y’isoko y’imiti igabanya ubukana n’imiti igabanya ubukana ku bigo by’ubuvuzi rusange mu Bushinwa mu gice cya mbere cya 2022 yarenze miliyari 2.9.Imiti ya Qilu yakomeje kuyobora isoko.Itsinda ryimiti ya Zhengda Tianqing ryihutiye muri TOP2.Imiti mishya ya Hengrui yo mu cyiciro cya mbere yinjiye mu cyiciro cya gatatu cy’ubuvuzi, kandi icyiciro gishya cyo guhinduranya ibicuruzwa kiri hafi gutangira.
3.Ibice bibiri birwanya R&D birashyushye!Xinda n'andi masosiyete babonye isoko rifite agaciro ka miliyari zirenga 200
Vuba aha, isoko rya kabiri rirwanya ibiyobyabwenge ryashyushye: Kangfang Biotech na Summit Therapeutics bageze mu mahanga uruhushya rwo mu mahanga rugera ku madolari agera kuri miliyari 5 y’amadolari y’ibicuruzwa bibiri birwanya ibiyobyabwenge AK112, na Wuhan Youzhiyou Biotech, mu gihugu cy’ubushakashatsi bw’ibiyobyabwenge ndetse n’iterambere uruganda, rwatanze IPO isaba urutonde… Bitewe nisoko ryiza, ibiyobyabwenge byombi birwanya ubushakashatsi niterambere.Kugeza ubu, mu Bushinwa hari ubwoko 80 bwa antibodi ebyiri.Xinda Bio, Shiyao Holding, Roche, nibindi bifite ibicuruzwa bine cyangwa byinshi biri mubushakashatsi.Ibicuruzwa 13 bya farumasi ya Hengrui, nka SHR-1701, Zanidatamab ya Baiji Shenzhou, biri mu cyiciro cya III.Antibodies ebyiri zishingiye kuri CD47 / PD-L1 intego nizo zizwi cyane, kandi ibicuruzwa bitanu biri kugeragezwa kwa kliniki.CDE yashyizeho amahame ngenderwaho ayobora ibibazo bikeneye kwitabwaho byihutirwa mu bushakashatsi bw’amavuriro no guteza imbere imiti ibiri irwanya ibibyimba, Kuyobora ibigo gukora ubushakashatsi bw’ubuvuzi bwa siyansi no guteza imbere antibody ebyiri.
4.Icyorezo cya grippe mbi cyane mu myaka icumi ishize!Umubare w'ibitaro muri leta zunze ubumwe za Amerika wiyongereye
Raporo yo ku nshuro ya 5 yo mu gace ka Axios, urubuga rw’amakuru yo muri Amerika, ibicurane bibi cyane mu myaka irenga icumi byibasiye gahunda y’ubuvuzi n’ubuzima iri hafi gusenyuka kubera icyorezo cya COVID-19 hamwe n’ubuhumekero. virusi (RSV).
Biravugwa ko ibicurane byateje leta hafi ya zose kurwego rwo hejuru cyangwa rwinshi cyane rwibikorwa bya grippe.
Nk’uko ikigo cyo muri Amerika gishinzwe kurwanya no gukumira indwara (CDC) kibitangaza, umubare w’ibicurane bijyanye n’ibicurane mu bitaro bya Thanksgiving wikubye hafi kabiri icyumweru gishize, kikaba ari cyo kinini kuva mu gihe cy’ibicurane 2010-2011.Muri bo, abantu bakuru bafite imyaka 65 nayirenga hamwe nabana bafite imyaka 4 nayirenga baribasiwe cyane cyane niba bafite ibibazo byubuzima.
Icyakora, Abanyamerika bagera kuri 40% bavuze ko badateganya gukingira ibicurane muri iki gihembwe, ahanini kubera ko bahangayikishijwe n'ingaruka mbi cyangwa ingaruka z'urukingo.
Inzobere mu buzima rusange zavuze ko mu myaka ibiri ishize, masike n’izindi ngamba zo gukumira icyorezo cya COVID-19 ahanini zahagaritse ibicurane kandi bikabuza kwanduza ibihe.Ariko, mugihe abantu basubiye mubuzima bwabo bwicyorezo, nabo bashobora kwibasirwa cyane.
Umwaka ushize, itsinda ry’ubushakashatsi ryahanuye ko ingamba zo gukingira umuntu zimaze gukurwaho, icyorezo cy’abana kizongera kwiyongera ku buryo bugaragara.Abashakashatsi basabye ko hashyirwa mu bikorwa “gahunda yo gukingira” ikomeye.
CDC ivuga ko, kugeza ubu, byibuze abantu miliyoni 8.7 barwaye, 78000 bari mu bitaro naho 4500 bapfuye mu gihe cy’ibicurane.
Nk’uko CNN ibitangaza, guverinoma ya Biden yasezeranyije gutanga ibikoresho n'abakozi kugira ngo bafashe gahunda y’ubuzima yaho guhangana n’ibicurane by’ibicurane, ariko ntizatekereza gutangaza ko byihutirwa mu buzima rusange.
Nk’uko imibare ya CDC ibigaragaza, hagati ya 2009 na 2022, umubare w’ibicurane by’ibitaro by’abanyamerika bakuze bo muri Afurika uri hejuru ya 80% ugereranije n’abakuze b'abazungu.Ariko, mugihe c'ibicurane 2021-2022, abakuze batageze kuri 43% byabanyamerika, Abanyamerika n’Abanyamerika kavukire.
Mu ibaruwa yandikiwe ibihugu, umunyamabanga wa Minisiteri y’ubuzima n’ibikorwa by’Amerika muri Amerika, Xavier Bessela, yanditse ko guverinoma ihuriweho na Leta ishobora kugira icyo ikora kugira ngo ifashe gahunda y’ubuvuzi ihura n’igitutu, nko kwemerera ibitaro bifite abakozi babuze uburenganzira bwo gusonerwa kwiyongera ubushobozi bwo kuvura abarwayi, cyangwa bigatuma bishoboka cyane kohereza abarwayi bafite ibicurane, COVID-19 cyangwa RSV.
Ubuvuzi bwa JinDunifite ubufatanye burambye bwubushakashatsi nubushakashatsi hamwe na tekinoroji yo muri kaminuza zo mu Bushinwa.Hamwe n'ubuvuzi bukomeye bwa Jiangsu, bufitanye umubano w'igihe kirekire n'Ubuhinde, Aziya y'Amajyepfo y'Uburasirazuba, Koreya y'Epfo, Ubuyapani n'andi masoko.Itanga kandi isoko ryisoko nogurisha mubikorwa byose kuva hagati kugeza ibicuruzwa byarangiye API.Koresha ibikoresho byegeranijwe bya Yangshi Chemical muri chimie ya fluor kugirango utange serivisi zidasanzwe zo gutunganya imiti kubafatanyabikorwa.Tanga uburyo bushya bwo gukora no gukora ubushakashatsi bwanduye kubakiriya.
Ubuvuzi bwa JinDun bushimangira gushinga itsinda rifite inzozi, gukora ibicuruzwa byiyubashye, byitondewe, bikomeye, kandi byose bigasohoka kugirango ube umufatanyabikorwa wizewe ninshuti yabakiriya! Umwe mubatanga ibisubizo bihagarika ibisubizo, R&D yihariye hamwe na serivise zitanga umusaruro kubunzi ba farumasi na APIs, abahangaumusaruro wimiti yihariye(CMO) hamwe na farumasi yihariye ya R&D hamwe nabatanga serivisi (CDMO).Jindun azaguherekeza gukoresha COVID-19.
Igihe cyo kohereza: Ukuboza-16-2022